Intratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression

Title
Intratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 26, Issue 1, Pages 14-25
Publisher
Mary Ann Liebert Inc
Online
2014-11-08
DOI
10.1089/hum.2014.015

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started